AstraZeneca
Associate Director, Translational Medicine Lead
$142k–$213.6k base
- Location
- South San Francisco, CA (CA)
- Pay
- $142k–$213.6k base
- Posted
- Posted yesterday (employer shows the date only)
- Source
- Workday (employer's applicant tracking system)
- Category
- R&D/Science
- Industry
- Pharma/Biotech
Application: Workday — account required, long form — you fill it in on the employer's site.
UNTIL never charges to apply and never asks for payment or personal info on behalf of employers.
Apply kitYour saved details, ready to copy
From the employer's posting
Location is flexible Gaithersburg, MD or South San Francisco, CA
About AstraZeneca
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company committed to the discovery, development, and commercialization of prescription medicines for some of the world's most serious diseases. Within Hematology R&D, we drive a combination-focused pipeline across immuno-oncology, tumor drivers and resistance, DNA damage response, antibody-drug conjugates, cell therapy, and epigenetics to address unmet needs in hematologic cancers. Our mission is to eliminate cancer as a cause of death.
Translational Medicine — Hematology
The Translational Medicine (TM) function transforms hematological cancer biology into actionable insights that guide therapeutic development and clinical decision-making. Embedded within the Hematology R&D division, TM is the single point of accountability for robust, scientifically driven biomarker strategies across all hematology programs — leukemia, lymphoma, and myeloma. The team collaborates closely with Preclinical Bioscience, Clinical Development, Clinical Operations, Clinical Pharmacology, and Precision Diagnostic Development to deliver fit-for-purpose assays, translational data packages, and patient selection strategies across the full development spectrum.
Role Summary
We are seeking a highly motivated Associate Director, Translational Medicine Lead to develop and lead hypothesis-driven biomarker strategies and translational science across our B-cell malignancy programs, spanning B-cell Acute Lymphoblastic Leukemia (B-ALL), B-cell Chronic Lymphocytic Leukemia (B-CLL), and Non-Hodgkin Lymphoma (NHL), including combination therapy studies. The role will translate disease biology and therapeutic mechanism into actionable plans for patient stratification/selection, target engagement, pharmacodynamic assessment, depth and durability of response, and mechanisms of resistance. This is a 100% Translational Medicine role supporting large molecules (T-cell engaging bispecifics, ADCs, monoclonal antibodies), small molecules, and cell-based therapies.
The Associate Director will be accountable for the translational strategy for assigned programs and clinical trials, representing the TM function within cross-functional program teams from preclinical stages through Phase 1/2 and, where required, into Phase 3. The successful candidate brings established knowledge of B-cell disease biology, demonstrated experience with T-cell engaging bispecifics and/or ADCs, and a track record of delivering biomarker strategies in hematology drug development.
Key Responsibilities
Translational Strategy & Delivery
- Develop and own translational science strategies for assigned B-cell malignancy programs — including B-ALL, B-CLL, and NHL — from preclinical stages through Phase 1/2 and Phase 3 clinical studies.
- Generate and integrate disease linkage data to support indication selection, patient stratification, and targeted population definition across monotherapy and combination therapy studies.
- Measure and interpret target engagement, pharmacodynamic (PD) biomarkers, and mechanism of action (MoA) data to inform dose selection and clinical decision-making across multiple concurrent programs or trials.
- Define and investigate mechanisms of resistance to B-cell targeted therapies across modalities using longitudinal and relapse clinical samples.
- Analyze B-cell tumor biology, cancer pathway interactions, and tumor microenvironment features in patient samples to guide rational drug combination strategies and inform combination trial design.
Biomarker & Assay Development
- Lead development and deployment of fit-for-purpose translational assays (flow cytometry, IHC/IF, molecular, MRD-adjacent panels) both internally and through external CRO/laboratory partners.
- Collaborate with Precision Diagnostics to ensure appropriate sample collection, traceability, and documentation; support CDx pathway discussions where warranted.
- Contribute translational and biomarker content for regulatory interactions and filings, including health authority briefing materials where appropriate.
Cross-functional Collaboration & Portfolio Influence
- Represent the TM function within program-level cross-functional teams (eGPT and equivalent), acting as a scientific partner to Clinical Development, Oncology Research, Clinical Operations, and Product Development, ensuring alignment with overall asset strategy, disease biology, and key clinical development milestones.
- Embed biomarker strategies and translational endpoints into clinical study protocols, sample collection manuals, statistical analysis plans, and data delivery cadences for hematology studies across Phase 1 through Phase 3.
- Contribute to translational strategy across the broader B-cell hematology portfolio, connecting insights from individual programs to inform indication expansion and combination hypotheses.
…
Similar live roles
- Senior Research Scientist, Multimodal Deep Learning and Risk Prediction
Heartflow · Posted 11h agoSan Francisco, California - Director, Clinical Operations
Gilead Sciences · Posted today - Principal Scientist / Sr. Principal Scientist - Cryo-EM
Eli Lilly · Posted todayUS, San Diego CA - Clinical Lab Technician - Sequenom
Labcorp · Posted todaySan Diego CA - Associate Machinist, R&D
Stryker · Posted yesterdayIrvine, California - Senior Scientist, Discovery Analytical Research (on-site)
Merck · Posted yesterdayUSA - California - South San Francisco (Grand Ave)